Current concepts of the pathogenesis of acquired middle ear cholesteatoma;Aktuelle Konzepte zur Pathogenese des erworbenen Cholesteatoms

Laryngo- Rhino- Otologie

Volumn 90, Issue 1, 2011, Pages 38-51

  Welkoborsky, H J ^a  

^a NONE

Author keywords

cholesteatoma; cytokine; etiology; middle ear; pathogenesis

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR;

APOPTOSIS; ARTICLE; BONE MATRIX; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CHOLESTEATOMA; EAR INFECTION; KERATINOCYTE; LANGERHANS CELL; MACROPHAGE; MIDDLE EAR CHOLESTEATOMA; OSTEOCLAST; PATHOGENESIS; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; T LYMPHOCYTE; TYMPANOSTOMY TUBE;

BONE MATRIX; CELL DIFFERENTIATION; CELL DIVISION; CELL MOVEMENT; CHOLESTEATOMA, MIDDLE EAR; CYTOKINES; DISEASE PROGRESSION; EPITHELIAL CELLS; EUSTACHIAN TUBE; HUMANS; KERATINOCYTES; LANGERHANS CELLS; MACROPHAGES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OSTEOCLASTS; OSTEOLYSIS; OTITIS MEDIA; T-LYMPHOCYTES;

EID: 78650995799     PISSN: 09358943     EISSN: 14388685     Source Type: Journal    
DOI: 10.1055/s-0030-1268464     Document Type: Article

References (42)

1. Persaud R, Hajioff D, Trinidade A, et al. Evidence-based review of aetiopathogenic theories of congenital and acquired cholesteatoma. J Laryngol Otol 2007 121 1013-1019
2. Tos M. Relationship between secretory otitis in childhood and chronic otitis and its sequelae in adults. J Laryng Otol 1981 95 1011-1022
3. Cassano M, Cassano P. Retraction pockets of pars tensa in pediatric patients: clinical evolution and treatment. Int J Pediatr Otorhinolaryngol 2010 74 178-182
4. Sudhoff H, Tos M. Pathogenesis of attic cholesteatoma. Clinical and immunohistochemical support for the combination of retraction theory and proliferation theory. Am J Otol 2000 21 786-792
5. Yamamoto-Fukuda T, Hishikawa Y, Shibata Y, et al. Pathogenesis of middle ear cholesteatoma: a new model of experimentally induced cholesteatoma in Mongolian gerbils. Am J Pathol 2010 176 2602-2606
6. Ruedi L. Pathogenesis and surgical treatment of the middle ear cholesteatoma. Acta Otolaryngol (Stockh) Suppl 1978 361 1-45
7. Alves AL, Pereira CS, Ribeiro Fde A, et al. Analysis of histopathological aspects in acquired middle ear cholesteatoma. Braz J Otorhinolaryngol 2008 74 835-841
8. Sudhoff H, Tos M. Pathogenesis of sinus cholesteatoma. Eur Arch Otorhinolaryngol 2007 264 1137-1143
9. Spilsbury K, Miller I, Semmens JB, et al. Factors associated with developing cholesteatoma: A study of 45 980 children with middle ear disease. Laryngoscope 2010 120 625-630
10. Nankivell PC, Pothier DD. Surgery for tympanic membrane retraction pockets. Cochrane Database Syst Rev 2010 7 CD007943
11. Juhn SK, Jung MK, Hoffman MD, et al. The role of inflammatory mediators in the pathogenesis of otitis media and sequelae. Clin Exp Otorhinolaryngol 2008 1 117-138
12. Louw L. Acquired cholesteatoma pathogenesis: stepwise explanations. J Laryngol Otol 2010 124 587-593
13. Ricciardiello F, Cavaliere M, Mesolella M, et al. Notes on microbiology of cholesteatoma: clinical findings and treatment. Acta Otorhinolaryngol Ital 2009 29 197-202
14. Tokuriki M, Noda I, Saito T, et al. Gene expression analysis of human middle ear cholesteatoma using complementary DNA arrays. Laryngoscope 2003 113 808-814
15. Ecsedi S, Rakosy Z, Vizkeleti L, et al. Chromosomal imbalances are associated with increased proliferation and might contribute to bone destruction in cholesteatoma. Otolaryngol Head Neck Surg 2008 139 635-640
16. Jacob RS, Welkoborsky HJ, Mann WJ. Untersuchungen der Epithel-Stroma Interaktion beim Cholesteatom des Mittelohres. Laryngorhinootologie 2001 80 11-17
17. Welkoborsky HJ, Jacob RS, Hinni ML. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults. Eur Arch Otorhinolaryngol 2007 264 841-848
18. Friedland DR, Eernisse R, Erbe C, et al. Cholesteatoma growth and proliferation: posttranscriptional regulation by microRNA-21. Otol Neurotol 2009 30 998-1005
19. Yune TY, Byun JY. Expression of PTEN and phosphorylated Akt in human cholesteatoma epithelium. Acta Otolaryngol 2009 129 501-506
20. James AL, Chadha NK, Papsin BC, et al. Pediatric cholesteatoma and variants in the gene encoding connexion 26. Laryngoscope 2010 120 183-187
21. Jung MH, Lee JH, Cho JG, et al. Expressions of caspase-14 in human middle ear cholesteatoma. Laryngoscope 2008 118 1047-1050
22. Woo HJ, Park JC, Bae CH, et al. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma. Acta Otolaryngol 2009 129 624-629
23. Kuczkowski J, Sakowicz-Burkiewicz M, Izycka-Swieszewska E. Expression of the receptor activator for nuclear factor-kappaB ligand and osteoprotegerin in chronic otitis media. Am J Otolaryngol 2009 [Epub]
24. Olszewska E, Olszewski S, Borzym-Kluczyk M, et al. Role of N-acetyl-beta-d-hexosaminidase in cholesteatoma tissue. Acta Biochim Pol 2007 54 365-370
25. Rutkowska J, Olszewska E, Waniewska E, et al. Hexosoaminidase gene expression in cholesteatoma in adults. Otolaryngol Pol 2009 63 490-495
26. Hussein MR, Sayed RH, Abu-Dief EE. Immune cell profile in invasive cholesteatomas: Preliminary findings. Exp Mol Pathol 2010 [Epub]
27. Huisman MA, de Heer E, Ten Dijke P, et al. Transforming growth factor beta and wound healing in human cholesteatoma. Laryngoscope 2008 118 94-98
28. Xia M, Ding S, Zhang H, et al. Expression and significance of nuclear factor-kappa B ligand and correlation in the tissue of otits media with cholesteatoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2007 21 315-317
29. Ma Y, Ye S. The expression of receptor activator nuclear factor-kappaB ligand and osteoprotegerin in cholesteatoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2008 22 293-295
30. Nason R, Jung JY, Chole RA. Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis. J Assoc Res Otolaryngol 2009 10 151-160
31. Vitale RF, Ribeiro Fde A. The role of tumor necrosis factor-alpha (TNF-alpha) in bone resorption present in middle ear cholesteatoma. Braz J Otorhinolaryngol 2007 73 117-121
32. Suchozerbska-Jesionek D, Szymanski M, Kurzepa J, et al. Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma. J Otolaryngol Head Neck Surg 2008 37 628-632
33. Wang J, Yu LS. Expression of matrix metalloproteinase-2,9 in cholesteatoma from different positions. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2009 44 44-48
34. Juhasz A, Sziklai I, Rakosy Z, et al. Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas. Otol Neurotol 2009 30 559-565
35. Morales DS, Penido Nde O, da Silva ID, et al. Matrix metalloproteinase 2: an important genetic marker for cholesteatomas. Braz J Otorhinolaryngol 2007 73 51-57
36. Olszewska E, Borzym-Kluczyk M, Olszewski S, et al. Catabolism of glycoconjugates in chronic otitis media with cholesteatoma. J Investig Med 2007 55 248-254
37. Breitkreutz D, Stark HJ, Mirancea N, et al. Integrin and basement membrane normalization in mouse grafts of human keratinocytes - implications for epidermal hemostasis. Differentiation 1997 61 195-209
38. Helgaland T, Engelen B, Olsnes C, et al. In vitro cholesteatoma growth and secretion of cytokines. Acta Otolaryngol 2010 [Epub]
39. Park HR, Min SK, Min K, et al. Increased expression of p63 and surviving in cholesteatomas. Acta Otolaryngol 2009 129 268-272
40. Li S, Zhan H, Peng S. Expression of epidermal growth factor receptor, Ki67 and p16 in human middle ear cholesteatoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2008 22 987-991
41. Barbara M, Raffa S, Mure C, et al. Keratinocyte growth factor receptor (KGF-R) in cholesteatoma tissue. Acta Otolaryngol 2008 128 360-364
42. Dornelles Cde C, da Costa SS, Meurer L, et al. Comparison of acquired cholesteatoma between pediatric and adult patients. Eur Arch Otorhinolaryngol 2009 266 1553-1561